BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 2009
View Archived Issues
MedImmune presents monoclonal antibodies for rheumatoid arthritis at ACR scientific meeting
Read More
A-1010002 induces long-distance post-trauma neuronal regeneration in vivo
Read More
Favorable preclinical evaluation of CM-2395 supports future phase I trial in schizophrenia
Read More
IL-2 and TNF-alpha may predict response to palliative radiopharmaceutical therapy
Read More
Ligand Pharmaceuticals acquires Metabasis Therapeutics and its pipeline of products
Read More
Bionomics completes first stage of phase I trial of BNC-210 for anxiety disorders
Read More
PharmaGap reports results from NCI's in vitro anticancer screen of GAP-107B8
Read More
Biomarker analysis shows that VT-111 reduces cardiac damage in ACS patients
Read More
Preclinical studies demonstrate potential of JNJ-1930942 for treatment of cognitive dysfunction
Read More
PD-0360324 is safe and reduces levels of bone resorption marker in healthy subjects
Read More
Cycloset induces glycemic control in type 2 diabetes patients failing thiazolidinediones
Read More
Preclinical characteristics of phase II Pfizer antipsychotic PF-00217830 described
Read More
Alkermes commences phase I ALKS-37 trial for opioid-induced constipation
Read More
GlaxoSmithKline reports results from trial of the Pandemrix H1N1 vaccine
Read More
CHMP grants marketing authorization for Regeneron's rilonacept for CAPS
Read More
Abbott Japan and Eisai submit MAA in Japan for Humira in ankylosing spondylitis
Read More
Lundbeck discloses P2X7 receptor antagonists for use as analgesics
Read More
Sterix claims 11beta-HSD1 inhibitors for treating diabetes and other conditions
Read More
Dainippon Sumitomo Pharma discovers 5-HT4 receptor agonists for GI dysfunction
Read More
E.U. approves Novartis' fully human monoclonal antibody Ilaris for CAPS
Read More
Results reported from clinical trial of Adimmune's H1N1 vaccine
Read More
Vertex reports interim results for telaprevir-based regimens in hepatitis C
Read More
AMPK activator Debio-0930 licensed to Mercury Therapeutics and Debiopharm
Read More
Nabi Biopharmaceuticals takes part in phase IIb study of NicVAX vaccine
Read More
AstraZeneca withdraws submissions from EMEA and FDA for Zactima in NSCLC
Read More
ThromboGenics and BioInvent complete recruitment into phase II trial of TB-402 in DVT
Read More
Nektar Therapeutics completes enrollment ahead of schedule in phase II NKTR-102 trial
Read More
